Elanco Financial Statements From 2010 to 2024
| 5EA Stock | EUR 11.95 0.19 1.62% |
Check Elanco Animal financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Elanco Animal's main balance sheet or income statement drivers, such as , as well as many indicators such as . Elanco financial statements analysis is a perfect complement when working with Elanco Animal Valuation or Volatility modules.
Elanco |
Elanco Animal Health Company Current Valuation Analysis
Elanco Animal's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Elanco Animal Current Valuation | 10.92 B |
Most of Elanco Animal's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Elanco Animal Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Elanco Animal Health has a Current Valuation of 10.92 B. This is 23.97% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The current valuation for all Germany stocks is 34.31% higher than that of the company.
Elanco Animal Health Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Elanco Animal's current stock value. Our valuation model uses many indicators to compare Elanco Animal value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Elanco Animal competition to find correlations between indicators driving Elanco Animal's intrinsic value. More Info.Elanco Animal Health is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Elanco Animal's earnings, one of the primary drivers of an investment's value.About Elanco Animal Financial Statements
Elanco Animal stakeholders use historical fundamental indicators, such as Elanco Animal's revenue or net income, to determine how well the company is positioned to perform in the future. Although Elanco Animal investors may analyze each financial statement separately, they are all interrelated. For example, changes in Elanco Animal's assets and liabilities are reflected in the revenues and expenses on Elanco Animal's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Elanco Animal Health. Please read more on our technical analysis and fundamental analysis pages.
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. ELANCO ANIMAL operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange. It employs 10200 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Elanco Stock
When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:Check out the analysis of Elanco Animal Correlation against competitors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.